BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 23180826)

  • 1. Versican 3'-untranslated region (3'-UTR) functions as a ceRNA in inducing the development of hepatocellular carcinoma by regulating miRNA activity.
    Fang L; Du WW; Yang X; Chen K; Ghanekar A; Levy G; Yang W; Yee AJ; Lu WY; Xuan JW; Gao Z; Xie F; He C; Deng Z; Yang BB
    FASEB J; 2013 Mar; 27(3):907-19. PubMed ID: 23180826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Versican 3'-untranslated region (3'UTR) promotes dermal wound repair and fibroblast migration by regulating miRNA activity.
    Yang W; Yee AJ
    Biochim Biophys Acta; 2014 Jul; 1843(7):1373-85. PubMed ID: 24594381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-1 and microRNA-499 downregulate the expression of the ets1 proto-oncogene in HepG2 cells.
    Wei W; Hu Z; Fu H; Tie Y; Zhang H; Wu Y; Zheng X
    Oncol Rep; 2012 Aug; 28(2):701-6. PubMed ID: 22664953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lentivirus-mediated overexpression of microRNA-199a inhibits cell proliferation of human hepatocellular carcinoma.
    Jia XQ; Cheng HQ; Qian X; Bian CX; Shi ZM; Zhang JP; Jiang BH; Feng ZQ
    Cell Biochem Biophys; 2012 Jan; 62(1):237-44. PubMed ID: 21847633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-214 inhibits cell growth in hepatocellular carcinoma through suppression of β-catenin.
    Wang X; Chen J; Li F; Lin Y; Zhang X; Lv Z; Jiang J
    Biochem Biophys Res Commun; 2012 Nov; 428(4):525-31. PubMed ID: 23068095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-206 inhibits cell proliferation, invasion, and migration by down-regulating PTP1B in hepatocellular carcinoma.
    Yang Q; Zhang L; Zhong Y; Lai L; Li X
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 31048362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo.
    He XX; Chang Y; Meng FY; Wang MY; Xie QH; Tang F; Li PY; Song YH; Lin JS
    Oncogene; 2012 Jul; 31(28):3357-69. PubMed ID: 22056881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-615-5p is restrictedly expressed in cirrhotic and cancerous liver tissues and its overexpression alleviates the tumorigenic effects in hepatocellular carcinoma.
    El Tayebi HM; Hosny KA; Esmat G; Breuhahn K; Abdelaziz AI
    FEBS Lett; 2012 Sep; 586(19):3309-16. PubMed ID: 22819824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-211 suppresses hepatocellular carcinoma by downregulating SATB2.
    Jiang G; Cui Y; Yu X; Wu Z; Ding G; Cao L
    Oncotarget; 2015 Apr; 6(11):9457-66. PubMed ID: 25888635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [miR-378 suppresses HBV-related hepatocellular carcinoma tumor growth by directly targeting the insulin-like growth factor 1 receptor].
    Li LH; Gao Q; Wang XY; Guo ZJ
    Zhonghua Gan Zang Bing Za Zhi; 2013 Aug; 21(8):609-13. PubMed ID: 24119742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiRNA199a-3p suppresses tumor growth, migration, invasion and angiogenesis in hepatocellular carcinoma by targeting VEGFA, VEGFR1, VEGFR2, HGF and MMP2.
    Ghosh A; Dasgupta D; Ghosh A; Roychoudhury S; Kumar D; Gorain M; Butti R; Datta S; Agarwal S; Gupta S; Krishna Dhali G; Chowdhury A; Schmittgen TD; Kundu GC; Banerjee S
    Cell Death Dis; 2017 Mar; 8(3):e2706. PubMed ID: 28358369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity.
    Su H; Yang JR; Xu T; Huang J; Xu L; Yuan Y; Zhuang SM
    Cancer Res; 2009 Feb; 69(3):1135-42. PubMed ID: 19155302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-122 targets an anti-apoptotic gene, Bcl-w, in human hepatocellular carcinoma cell lines.
    Lin CJ; Gong HY; Tseng HC; Wang WL; Wu JL
    Biochem Biophys Res Commun; 2008 Oct; 375(3):315-20. PubMed ID: 18692484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. microRNA-141 inhibits cell proliferation and invasion and promotes apoptosis by targeting hepatocyte nuclear factor-3β in hepatocellular carcinoma cells.
    Lin L; Liang H; Wang Y; Yin X; Hu Y; Huang J; Ren T; Xu H; Zheng L; Chen X
    BMC Cancer; 2014 Nov; 14():879. PubMed ID: 25425543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A functional screening identifies five microRNAs controlling glypican-3: role of miR-1271 down-regulation in hepatocellular carcinoma.
    Maurel M; Jalvy S; Ladeiro Y; Combe C; Vachet L; Sagliocco F; Bioulac-Sage P; Pitard V; Jacquemin-Sablon H; Zucman-Rossi J; Laloo B; Grosset CF
    Hepatology; 2013 Jan; 57(1):195-204. PubMed ID: 22865282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NF-κB signaling relieves negative regulation by miR-194 in hepatocellular carcinoma by suppressing the transcription factor HNF-1α.
    Bao C; Li Y; Huan L; Zhang Y; Zhao F; Wang Q; Liang L; Ding J; Liu L; Chen T; Li J; Yao M; Huang S; He X
    Sci Signal; 2015 Jul; 8(387):ra75. PubMed ID: 26221053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-198 inhibits migration and invasion of hepatocellular carcinoma cells by targeting the HGF/c-MET pathway.
    Tan S; Li R; Ding K; Lobie PE; Zhu T
    FEBS Lett; 2011 Jul; 585(14):2229-34. PubMed ID: 21658389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WNT1 Gene from WNT Signaling Pathway Is a Direct Target of miR-122 in Hepatocellular Carcinoma.
    Ahsani Z; Mohammadi-Yeganeh S; Kia V; Karimkhanloo H; Zarghami N; Paryan M
    Appl Biochem Biotechnol; 2017 Mar; 181(3):884-897. PubMed ID: 27687586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-206, down-regulated in hepatocellular carcinoma, suppresses cell proliferation and promotes apoptosis.
    Yunqiao L; Vanke H; Jun X; Tangmeng G
    Hepatogastroenterology; 2014; 61(133):1302-7. PubMed ID: 25436301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells.
    Salvi A; Sabelli C; Moncini S; Venturin M; Arici B; Riva P; Portolani N; Giulini SM; De Petro G; Barlati S
    FEBS J; 2009 Jun; 276(11):2966-82. PubMed ID: 19490101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.